Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry

详细信息    查看全文

• 作者：Amit Noheria ; MBBS ; SM^a ; Peter Shrader ; MA^b ; Jonathan P. Piccini ; MD ; MHS^b ; Gregg C. Fonarow ; MD^c ; Peter R. Kowey ; MD^d ; Kenneth W. Mahaffey ; MD^e ; Gerald Naccarelli ; MD^f ; Peter A. Noseworthy ; MD^g ; James A. Reiffel ; MD^h ; Benjamin A. Steinberg ; MD ; MHS^b ; Laine E. Thomas ; PhD ; MPH^b ; Eric D. Peterson ; MD ; MPH^b ; Bernard J. Gersh ; MBChB ; DPhil^g ; ^{Gersh.Bernard@mayo.edu" class="auth_mail" title="E-mail the corresponding author} ; on behalf of the ORBIT-AF Investigators ; Patients
• 关键词：antiarrhythmic drugs ; atrial fibrillation ; rate control ; rhythm control
• 刊名：JACC: Clinical Electrophysiology
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：2
• 期：2
• 页码：221-229
• 全文大小：427 K

文摘

The study sought to evaluate clinical outcomes in clinical practice with rhythm control versus rate control strategy for management of atrial fibrillation (AF).

Background

Randomized trials have not demonstrated significant differences in stroke, heart failure, or mortality between rhythm and rate control strategies. The comparative outcomes in contemporary clinical practice are not well described.

Methods

Patients managed with a rhythm control strategy targeting maintenance of sinus rhythm were retrospectively compared with a strategy of rate control alone in a AF registry across various U.S. practice settings. Unadjusted and adjusted (inverse-propensity weighted) outcomes were estimated.

Results

The overall study population (N = 6,988) had a median of 74 (65 to 81) years of age, 56% were males, 77% had first detected or paroxysmal AF, and 68% had CHADS₂ score ≥2. In unadjusted analyses, rhythm control was associated with lower all-cause death, cardiovascular death, first stroke/non–central nervous system systemic embolization/transient ischemic attack, or first major bleeding event (all p < 0.05); no difference in new onset heart failure (p = 0.28); and more frequent cardiovascular hospitalizations (p = 0.0006). There was no difference in the incidence of pacemaker, defibrillator, or cardiac resynchronization device implantations (p = 0.99). In adjusted analyses, there were no statistical differences in clinical outcomes between rhythm control and rate control treated patients (all p > 0.05); however, rhythm control was associated with more cardiovascular hospitalizations (hazard ratio: 1.24; 95% confidence interval: 1.10 to 1.39; p = 0.0003).

Conclusions

Among patients with AF, rhythm control was not superior to rate control strategy for outcomes of stroke, heart failure, or mortality, but was associated with more cardiovascular hospitalizations.